This fibrogenic effect was confirmed in the chronic CCl4 model, where mice lacking IL-22 signaling (Il22ra1-/-) exhibited reduced hepatic fibrosis compared to their wild-type counterparts (141). Here, IL22 is linked to Hepatic fibrosis.